Results 1 to 10 of about 10,915 (160)
Journal of Diabetes, Volume 15, Issue 1, Page 27-35, January 2023., 2023 Highlights This study constructed the first 5‐year all‐cause mortality risk prediction model for patients with type 2 diabetes mellitus in south China. This well‐performing model, using highly accessible predictors collected in routine clinical settings, provides a powerful tool for clinicians to identify high‐risk diabetic patients.
Jiying Qi +10 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 247-260, April 2022., 2022 Highlights Phosphoinositide 3‐kinase (PI3K)/Akt signaling is an emerging promising therapeutic target for diabetes. Modulation of the PI3K/Akt signaling pathway, via protein and peptide‐based biologics, parasite‐derived molecules, plant extracts, or through microRNA interactions, will regulate the processes that determine the function of β‐cells and ...
Inah Camaya +2 more
wiley +1 more source
Chinese Clinical Named Entity Recognition with ALBERT and MHA Mechanism
Evidence-Based Complementary and Alternative Medicine, Volume 2022, Issue 1, 2022., 2022 Traditional clinical named entity recognition methods fail to balance the effectiveness of feature extraction of unstructured text and the complexity of neural network models. We propose a model based on ALBERT and a multihead attention (MHA) mechanism to solve this problem.
Dongmei Li +4 more
wiley +1 more source
Chinese Medical Entity Recognition Model Based on Character and Word Vector Fusion
Scientific Programming, Volume 2021, Issue 1, 2021., 2021 The medical information carried in electronic medical records has high clinical research value, and medical named entity recognition is the key to extracting valuable information from large‐scale medical texts. At present, most of the studies on Chinese medical named entity recognition are based on character vector model or word vector model.
Qinghui Zhang +5 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2021 目的筛查与肝癌(HCC)相关的自身抗体并对其诊断肝癌的临床价值进行初步评估。方法制备用于自身抗体多重检测的液相芯片,对40例肝炎、32例肝硬化、48例肝癌及30例健康对照组血清进行检测,比较自身抗体IgG水平,筛选与肝癌相关的自身抗体,绘制ROC曲线评估其肝癌的诊断价值,并分析肝癌相关自身抗体与常见生化指标的相关性。结果肝炎、肝硬化、肝癌组的SSA/Ro、tTG、LC1、PR3、Scl-70、Mi-2、MPO和TIF1-γ自身抗体水平均显著高于正常对照组 ...
肖静 +8 more
doaj
Study on the tumor suppress mechanisms of ARID1A in hepatocellular carcinoma [PDF]
, 2015 肝细胞癌（Hepatocellularcarcinoma，HCC）（简称肝癌）是世界上，特别是中国，发病率最高的恶性肿瘤之一。据世界卫生组织估计，肝癌是世界上癌症相关死亡的第二大原因。应对肝癌，传统有效治疗手段就是肝癌切除或者肝移植。近些年射频消融和新兴化疗药物也被用来治疗肝癌。尽管对肝癌的诊断与治疗策略有长足的改进，但是肝癌晚期的病人还是容易发展转移，而且由于肝癌切除术后高频复发，病人的预后生存期才不足数月。鉴于现有的诊疗手段不足以彻底根治肝癌 ...
何飞
core
Mechanisms of activity hepatic stellate cells induced myeloid-derived suppressor cells accumulation and migration [PDF]
, 2015 原发性肝癌（hepatocellularcarcinoma，HCC）是全球第五大常见的恶性肿瘤，在肿瘤致死的病因中排名第三位。在全球，每年有超过50万人死于肝癌，且一半以上在中国。随着科学研究的发展，科研人员发现肝癌的发生发展不仅仅是病毒感染、环境因素、基因突变这些因素，肿瘤微环境对肿瘤的发生、发展、复发转移有着重要作用。肝脏是一个具有“免疫特赦”的脏器，肝癌微环境中的非实质细胞及其细胞因子是肝癌的免疫逃逸，复发转移的重要因素。 肝星状细胞（hepaticstellatecell，HSCs ...
许雅苹
core
Zhongguo shiyan zhenduanxue, 2020 目的探讨S1P lyase在肝癌中的表达情况,及其对肝癌预后的影响。方法选取桂林医学院附属医院54例肝细胞癌患者,real-time PCR分析S1P lyase在54对肝细胞癌癌组织及癌旁组织中的表达,运用统计学方法探讨S1P lyase表达与肝癌临床病理特征的关系;利用Kaplan-Meier分析S1P lyase对肝癌预后的影响;应用STRING数据库初步探讨神经鞘脂信号通路中可能与S1P lyase相互作用的信号分子。结果 S1P lyase在肝癌组织中的表达明显低于癌旁组织 ...
邱志东 +3 more
doaj